AzTrials
AzTrials

Reconstruction of the Posterior Membranous LabyrinthNCT03295929

3D Model of Posterior Membranous Labyrinth of the Inner Ear

An observational study of Reconstruction of the Posterior Membranous Labyrinth, run by University Hospital, Strasbourg, France at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this work is to create a three-dimensional (3D) finite element model (FEM) of the human posterior membranous labyrinth, based on in vivo inner ear magnetic resonance imaging (MRI). Read more about this study

Who is it for?
Ages 18 years and older
How many people
1 participants
Where
1 siteFrance
Study dates
19 Oct 2017to Sep 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Adult who has performed an imaging of the inner ear

Who may be able to join

  • Patient aged 18 or over
  • Adult who has performed an imaging of the inner ear

Who cannot join

  • Refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Service D'Orl Et de Chirurgie Cervico-Faciale

    Strasbourg, 67091

    Anne CHARPIOT, MD, PhD, 33 3 88 12 76 49, anne.charpiot@chru-strasbourg.fr

    Hella VUONG, MD, 33 6 50 66 82 23, hella.vuong@chru-strasbourg.fr

    Recruiting

Other trials in France

About this study

Official title: 3D Finite Element Model of Posterior Membranous Labyrinth From in Vivo MRI of Human Temporal Bone

The aim of this work is to create a three-dimensional (3D) finite element model (FEM) of the human posterior membranous labyrinth, based on in vivo inner ear magnetic resonance imaging (MRI). This model has a pedagogical interest, and can serve as a basis for reflection in cases of atypical benign paroxysmal positional vertigos. It can also serve for mechanical studies of vestibular physiology.

Keywords
3D model, Inner ear

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of dimensions of the model to study the validity of the geometry

    Measured: Creation of 3D model: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2017
  2. Study start19 Oct 2017
  3. Primary completionSep 2018 (estimated)
  4. Study completionSep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
1 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03295929
Sponsor's protocol ID
6815
Status last verified
Sep 2017
First submitted
22 Sep 2017
Last updated
27 Feb 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Reconstruction of the Posterior Membranous Labyrinth, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anne CHARPIOT, MD, PhD (33 3 88 12 76 49, anne.charpiot@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of dimensions of the model to study the validity of the geometry (time frame: Creation of 3D model: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in